Chargement en cours...
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
BACKGROUND: Human species C adenovirus serotype 5 (Ad5) is the archetype oncolytic adenovirus and has been used in the vast majority of preclinical and clinical tests. While Ad5 can be robust, species C Ad6 has lower seroprevalence, side effects, and appears to be more potent as a systemic therapy a...
Enregistré dans:
| Publié dans: | Oncolytic Virother |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5939883/ https://ncbi.nlm.nih.gov/pubmed/29765912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S155946 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|